Comparison
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696 vs 3q26q28 Deletion Syndrome C6010434
Clinical comparison between 46 XY Difference OF Sex Development Due TO A Defect IN Testosterone Metabolism BY Peripheral Tissue and 3q26q28 Deletion Syndrome for differential diagnosis and treatment planning.
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
A condition where the body cannot properly convert testosterone to DHT in peripheral tissues. Affects 46,XY individuals, causing atypical genital development. Treatment involves hormone replacement.
3q26q28 Deletion Syndrome C6010434
A genetic condition involving deletion of part of chromosome 3q26q28, typically causing developmental delays, growth issues, and multiple congenital differences.
6 comparison axes
Onset
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
0-0
3q26q28 Deletion Syndrome C6010434
Variable
Onset patterns differ
Severity
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
severe
3q26q28 Deletion Syndrome C6010434
moderate
Different severity levels
Chronic
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
Chronic
3q26q28 Deletion Syndrome C6010434
Chronic
Differing course
Communicable
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
No
3q26q28 Deletion Syndrome C6010434
No
Different transmission
Body System
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
reproductive
3q26q28 Deletion Syndrome C6010434
congenital
Same/different system
Category
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
endocrine
3q26q28 Deletion Syndrome C6010434
genetic
Different category
Bottom line
46-xy-difference-of-sex-development-due-to-a-defect-in-testosterone-metabolism-by-peripheral-tissue-C5816696 and 3q26q28-deletion-syndrome-C6010434 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696 | 3q26q28 Deletion Syndrome C6010434 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development is the described feature in 46,XY individuals. | Genital phenotype is not established by the supplied description. | High |
| Development and growth | Global developmental delay or growth failure is not established. | Developmental delay, growth issues, and congenital differences are typical. | High |
| Primary mechanism | Endocrine defect affecting peripheral testosterone metabolism. | Genetic deletion involving chromosome 3q26q28. | High |
When to favor each condition
Choose 46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696 when
46,XY infant with atypical genitalia
The source centers on impaired peripheral testosterone metabolism.
Moderate
Suspected androgen-pathway disorder
Category is endocrine rather than a chromosomal deletion.
Moderate
Hormone therapy is being considered
Source mentions hormone replacement, without specifying regimen.
Low
Choose 3q26q28 Deletion Syndrome C6010434 when
Developmental delay with congenital anomalies
These are the described features of the deletion syndrome.
Moderate
Suspected chromosomal copy-number variant
The condition is defined by a 3q26q28 deletion.
High
Multisystem congenital presentation
Source describes multiple congenital differences, not a single endocrine defect.
Moderate
How key tests differ
| Test | 46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696 | 3q26q28 Deletion Syndrome C6010434 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XY is expected; it does not prove the metabolic defect. | May be normal if the deletion is small. | Karyotype alone cannot distinguish these conditions. |
| Chromosomal microarray | No 3q26q28 deletion is expected from the description. | May identify deletion of 3q26q28. | Supports the deletion diagnosis when clinically correlated. |
| Androgen metabolite assessment | May suggest impaired testosterone-to-DHT metabolism; cutoffs are not supplied. | No characteristic endocrine pattern is established. | Abnormal results need specialist confirmation and are not a diagnosis alone. |
Prognosis comparison
46 Xy Difference Of Sex Development Due To A Defect In Testosterone Metabolism By Peripheral Tissue C5816696
- Outcome
- Chronic endocrine condition; long-term outcome is not established here.
- Factors
- Genital phenotype, hormone findings, and access to specialist care.
3q26q28 Deletion Syndrome C6010434
- Outcome
- Chronic genetic condition with variable developmental and congenital effects.
- Factors
- Deletion extent, associated anomalies, growth, and developmental support.
Time frame: Often recognized in infancy or childhood, but timing can vary.
No mortality or prevalence comparison is established from the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Genital and reproductive concerns | Atypical genital development may require individualized endocrine and surgical counseling. Specific genital complications are not established. Decisions should be multidisciplinary and patient-centered. |
| Neurodevelopment | Developmental impairment is not established by the source. Developmental delay is a described feature. Early developmental assessment is appropriate when delay is present. |
| Growth and congenital anomalies | Growth failure or multiple anomalies are not established. Growth issues and multiple congenital differences are described. Extent varies and should be assessed individually. |
Patient education highlights
- HighDifferent causes
One is an endocrine pathway problem in a 46,XY person; the other is a chromosomal deletion.
- HighTesting limits
An abnormal hormone result or genetic finding needs clinical correlation and is not automatically a complete diagnosis.
- MediumCare planning
Hormone treatment, surgery, development support, and genetic counseling depend on confirmed findings and personal goals.